Effector Therapeutics Inc (EFTR) — Free Cash Flow Generation Index
Effector Therapeutics Inc (EFTR) has a Free Cash Flow Generation Index of 1.00x as of June 2020. Free cash flow of $11.98 Million represents 1% of operating cash flow ($11.98 Million). Explore capital reinvestment ratio of Effector Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Effector Therapeutics Inc Free Cash Flow Generation Index (2020–2020)
Historical FCF Generation Index trend for Effector Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Effector Therapeutics Inc (EFTR) cash flow conversion.
Annual Free Cash Flow Generation for Effector Therapeutics Inc (2020–2020)
Year-by-year Free Cash Flow Generation Index for Effector Therapeutics Inc. Check EFTR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.99x | $13.68 Million | $13.84 Million | $154.00K | — |